IPAK Vaxxed vs Unvaxxed Study

04 December, 2020 By AVN admin

The AVN is delighted to announce that the first phase of the IPAK Vaxxed vs. Unvaxxed Study has been completed. Along with other advocates for informed vaccine choice the AVN helped to fund this study that the CDC refused to do.

Vaccination has been practised for well over 200 years so one would expect that in all that time, long-term studies comparing the overall health of groups of vaccinated and unvaccinated children and adults would have been performed. In all this time, despite the addition of dozens of newly-licensed vaccines, there has never been a long-term independent trial of children or adults who are vaccinated according to schedule compared with those who are completely unvaccinated. Until now.

On November 22, 2020, the study undertaken by Dr. James Lyons-Weiler of  The Institute for Pure and Applied Knowledge and Dr Paul Thomas M.D. was published in the International Journal of Environmental Research and Public Health.

Andre Angelantoni explains why this Landmark Study  is vital

This is a landmark paper as it compares whole-health outcomes of fully vaccinated vs unvaccinated children.

Why do we want to know this? The potential damage these drugs are doing is enormous because the immune system is tightly integrated with every other system in the body, including with the nervous system—and that includes the brain. The dilemma of vaccinating children is that we want to protect them because their immune systems are not yet fully developed—yet activating the immune system of a child’s delicate developing brain is very risky.

If one wants to understand whether children are overall more healthy with all these immunomodulatory drugs (a fancy way of saying “a drug that modifies the immune system”) than without them, the obvious study to perform is to check the health status of 100% vaccinated kids against those kids who have received zero vaccines.

What did the study find? In every measure examined, the fully vaccinated children had more problems than the completely unvaccinated children: more ear infections, more brain damage, more allergies, more dermatitis, more respiratory infections, more eczema—more everything. One category, ADHD, showed **zero** cases in the unvaccinated cohort vs the fully vaccinated cohort.


We performed a retrospective analysis spanning ten years of pediatric practice focused on patients with variable vaccination born into a practice, presenting a unique opportunity to study the effects of variable vaccination on outcomes. The average total incidence of billed office visits per outcome related to the outcomes were compared across groups (Relative Incidence of Office Visit (RIOV)). RIOV is shown to be more powerful than odds ratio of diagnoses. Full cohort, cumulative incidence analyses, matched for days of care, and matched for family history analyses were conducted across quantiles of vaccine uptake. Increased office visits related to many diagnoses were robust to days-of-care-matched analyses, family history, gender block, age block, and false discovery risk. Many outcomes had high RIOV odds ratios after matching for days-of-care (e.g., anemia (6.334), asthma (3.496), allergic rhinitis (6.479), and sinusitis (3.529), all significant under the Z-test). Developmental disorders were determined to be difficult to study due to extremely low prevalence in the practice, potentially attributable to high rates of vaccine cessation upon adverse events and family history of autoimmunity. Remarkably, zero of the 561 unvaccinated patients in the study had attention deficit hyperactivity disorder (ADHD) compared to 0.063% of the (partially and fully) vaccinated. The implications of these results for the net public health effects of whole-population vaccination and with respect for informed consent on human health are compelling. Our results give agency to calls for research conducted by individuals who are independent of any funding sources related to the vaccine industry. While the low rates of developmental disorders prevented sufficiently powered hypothesis testing, it is notable that the overall rate of autism spectrum disorder (0.84%) in the cohort is half that of the US national rate (1.69%). The practice-wide rate of ADHD was roughly half of the national rate. The data indicate that unvaccinated children in the practice are not unhealthier than the vaccinated and indeed the overall results may indicate that the unvaccinated pediatric patients in this practice are healthier overall than the vaccinated.


We can conclude that the unvaccinated children in this practice are not, overall, less healthy than the vaccinated and that indeed the vaccinated children appear to be significantly less healthy than the unvaccinated.

IPAK is moving on to Phase 2 of the study, in which they will focus on the comparison of health outcomes associated with live vs. non-live vaccines, aluminium-containing vaccines vs. non-aluminium containing vaccines, as well as studying the impact of individual vaccines on specific health outcome risks.

For more on a couple of smaller, independent studies conducted on this question where the results have been concerning – to say the least.
please see an earlier blog:

Vaccinated vs Unvaccinated